BvTIBauhinia variegata Trypsin Inhibitor (protein)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Biovest International Inc., Worcester BVTI 1.01 0.03 0.12 0.02 43.75
8 January 2010 - US biotech company Biovest International Inc (OTC: BVTI) said yesterday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to its personalised lymphoma vaccine BiovaxID.